| T2DM | type 2 diabetes mellitus |
| NAFLD | non-alcoholic fatty liver disease |
| CHD | coronary heart disease |
| MetS | metabolic syndrome |
| IGT | Impaired Glucose Tolerance |
| PCOS | Polycystic ovary syndrome |
| FBG | fasting blood glucose |
| HbA1c | hemoglobin A1c |
| TC | total cholesterol |
| TG | triglycerides |
| FINS | fasting insulin |
| LDL-C | low density lipoprotein cholesterol |
| HDL-C | high density lipoprotein cholesterol |
| Non-HDL-C | non-high density lipoprotein cholesterol |
| VLDL-C | very-low-density lipoprotein cholesterol |
| HDL | high density lipoprotein |
| HOMA-β | homeostasis model assessment β |
| HOMA-IR | homeostasis model assessment-insulin resistance |
| ISI | insulin sensitivity index |
| QUICKI | Quantitative Insulin Sensitivity Check Index |
| ALT | alanine aminotransferase |
| AST | aspartate aminotransferase |
| 8-OHdG | 8-Hydroxy-2′-deoxyguanosine |
| CML | carboxy methyl lysine |
| BMI | body mass index |
| BW | body weight |
| WC | Waist circumference |
| TNF-α | tumor necrosis factor-α |
| FFA | free fatty acid |
| CRP | C-reactive protein |
| hs-CRP | high sensitivity C-reactive protein |
| IL-6 | interleukin-6 |
| SOD | superoxide dismutase |
| MDA | malonaldehyde |
| LP(a) | lipoprotein(a) |
| MCP-1 | macrophage chemoattractant protein-1 |
| GSH | glutathione |
| TAC | total antioxidant capacity |
| PAB | pro-oxidant–antioxidant balance |
| PWV | pulse wave velocity |
| SUA | serum uric acid |
| γ-GTP | γ-glutamyl transpeptidase |
| 2hpp | 2-h postprandial glucose |
| IL-1β | interleukin-1β |
| IL-4 | interleukin-4 |
| VEGF | vascular endothelial growth factor |
| ox-LDL | oxidized low density lipoprotein |
| LPL | lipoprotein lipase |
| PPAR-γ | peroxisome proliferator-activated receptor |
| GOT | glutamic oxaloacetic transaminase |
| GPT | glutamate pyruvate transaminase |
| GRAS | generally recognized as safe |
| AGEs | advanced glycosylation end products |
| Cmax | maximum concentration |